FDA/CDC update Zika transmission risk data
CDC, in collaboration with FDA, has a process to define areas at increased risk for Zika virus transmission through blood or tissue donation. CDC identifies areas at increased risk for Zika virus transmission. This information informs travel guidance from CDC and donor screening recommendations from FDA. FDA has updated its donor screening recommendations base on CDC’s recently updated Zika risk map.